Dr. Matthew McKenzie is a Senior Lecturer
in Biomedical Science and a member of the Institute for Physical Activity and
Nutrition (IPAN) at Deakin. He undertook his PhD at St. Vincent’s Hospital,
Melbourne, studying mitochondrial disease pathogenesis in mouse models of
mitochondrial DNA (mtDNA) disease. This was followed by post-doctoral research
at University College London investigating mitochondrial calcium handling. Dr.
Matthew McKenzie returned to Australia in 2004, receiving an NHMRC Peter
Doherty Fellowship and a Career Development Fellowship to investigate
mitochondrial complex I biogenesis in disease at La Trobe University. In 2011,
Dr. Matthew McKenzie was appointed as a Research Group Leader at the Hudson
Institute of Medical Research and was awarded an ARC Future Fellowship to
support his research program. Dr. Matthew McKenzie relocated his research lab
to Deakin in 2018, where his current research focuses on the interactions
between mitochondrial fatty acid beta-oxidation (FAO) and oxidative phosphorylation
(OXPHOS) protein complexes and their importance in human disease pathology. His
teaching focus at Deakin is cell biology and biochemistry, with his appointment
as the Director for the Master of Biotechnology Course in 2023.
Short Biography
Dr. Matthew McKenzie is a Senior Lecturer
in Biomedical Science and a member of the Institute for Physical Activity and
Nutrition (IPAN) at Deakin. He undertook his PhD at St. Vincent’s Hospital,
Melbourne, studying mitochondrial disease pathogenesis in mouse models of
mitochondrial DNA (mtDNA) disease. This was followed by post-doctoral research
at University College London investigating mitochondrial calcium handling. Dr.
Matthew McKenzie returned to Australia in 2004, receiving an NHMRC Peter
Doherty Fellowship and a Career Development Fellowship to investigate
mitochondrial complex I biogenesis in disease at La Trobe University. In 2011,
Dr. Matthew McKenzie was appointed as a Research Group Leader at the Hudson
Institute of Medical Research and was awarded an ARC Future Fellowship to
support his research program. Dr. Matthew McKenzie relocated his research lab
to Deakin in 2018, where his current research focuses on the interactions
between mitochondrial fatty acid beta-oxidation (FAO) and oxidative phosphorylation
(OXPHOS) protein complexes and their importance in human disease pathology. His
teaching focus at Deakin is cell biology and biochemistry, with his appointment
as the Director for the Master of Biotechnology Course in 2023.